Pages that link to "Q33630104"
Jump to navigation
Jump to search
The following pages link to Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. (Q33630104):
Displaying 9 items.
- Drug-induced amino acid deprivation as strategy for cancer therapy (Q38657061) (← links)
- Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer (Q58781169) (← links)
- Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma (Q64102494) (← links)
- A bioengineered arginine-depleting enzyme as a long-lasting therapeutic agent against cancer (Q90121775) (← links)
- In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes (Q90383407) (← links)
- Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models (Q90683901) (← links)
- Role of tumor and host autophagy in cancer metabolism (Q92500806) (← links)
- Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition (Q92710277) (← links)
- Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1 (Q92744515) (← links)